跳至主要内容
临床试验/EUCTR2021-001801-56-AT
EUCTR2021-001801-56-AT进行中(未招募)1 期

Efficacy and Safety of a hyaluronic and lactic acid containing vaginal gel HydroSanta® Vaginalgel” for the treatment of vaginal dryness symptoms – a multicenter randomized two-arm study

Gynial GmbH0 个研究点目标入组 90 人开始时间: 2021年8月30日最近更新:
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
发起方
入组人数
90

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
Female

入选标准

  • Informed consent
  • Biological sex: female (women only)
  • Women with moderate or severe vaginal dryness
  • Age > 18 years
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • Currently under vaginal atrophy treatment
  • Vaginal infections such as trichomonas, candida, and bacterial vaginosis (BV)
  • Patients with breast cancer, uterine cancer or estrogen hormone-dependent tumors, and genital bleeding of unknown origin
  • Known allergy against ingredients of the study intervention (e.g. estriol)

研究者

发起方
Gynial GmbH

相似试验